Wolverine Trading
MRNA icon

Wolverine Trading’s Moderna MRNA Stock Holding History

Wolverine Trading’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,252
Closed -$1.19M – 5436
2024
Q4 		$1.19M Buy
+30,252
New +$1.45M ﹤0.01% 2484
2024
Q3 		– Sell
-2,080
Closed -$191K – 5170
2024
Q2 		$247K Sell
2,080
-20,379
-91% -$2.58M ﹤0.01% 3608
2024
Q1 		$2.39M Sell
22,459
-76,162
-77% -$7.68M ﹤0.01% 1473
2023
Q4 		$9.81M Buy
98,621
+80,944
+458% +$6.81M 0.01% 730
2023
Q3 		$1.83M Sell
17,677
-7,881
-31% -$879K ﹤0.01% 1657
2023
Q2 		$3.12M Buy
25,558
+22,085
+636% +$2.95M ﹤0.01% 1211
2023
Q1 		$512K Sell
3,473
-1,184
-25% -$195K ﹤0.01% 2480
2022
Q4 		$836K Buy
4,657
+2,696
+137% +$441K ﹤0.01% 1963
2022
Q3 		$232K Sell
1,961
-41,002
-95% -$6.22M ﹤0.01% 3432
2022
Q2 		$6.14M Sell
42,963
-27,514
-39% -$3.93M 0.01% 727
2022
Q1 		$12.3M Sell
70,477
-62,876
-47% -$10.6M 0.02% 604
2021
Q4 		$33.6M Buy
133,353
+112,706
+546% +$33M 0.04% 325
2021
Q3 		$7.82M Buy
20,647
+10,684
+107% +$3.94M 0.01% 971
2021
Q2 		$2.34M Sell
9,963
-28,134
-74% -$5.03M ﹤0.01% 1824
2021
Q1 		$4.51M Sell
38,097
-2,362
-6% -$342K 0.01% 1204
2020
Q4 		$4.5M Buy
40,459
+20,564
+103% +$2.08M 0.01% 1135
2020
Q3 		$1.4M Buy
+19,895
New +$1.39M ﹤0.01% 1763
2020
Q2 		– Sell
-13,677
Closed -$749K – 4977
2020
Q1 		$417K Buy
+13,677
New +$315K ﹤0.01% 2867

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Wolverine Trading's MRNA Position: Q1 2025 in Review

Wolverine Trading sold out of Moderna (MRNA) in Q1 2025, closing a stake of 30,252 shares — an estimated $1.19M sold.

Wolverine Trading first reported a position in MRNA in Q1 2020 and held it in 18 quarters. The position peaked at $33.6M in Q4 2021. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Wolverine Trading reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 30,252 Moderna shares in Q1 2025, an estimated $1.19M.
  • Wolverine Trading first reported a position in Moderna in Q1 2020 and held it in 18 quarters.
  • Wolverine Trading's Moderna position peaked at $33.6M in Q4 2021.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.